How This Biotech Wants to Become a Stem Cell Therapy Success Story

The world of stem cell-based medicine has had its fair share of disappointments and regulatory recriminations over wildly inflated claims. But Athersys CEO Gil Van Bokkelen says the stem cell field isn’t getting a fair shake. “It’s a misconception to say stem cells haven’t really delivered,” he tells Fortune in an interview. “This is a […]